As of November 6, 2026, Neogen Corp has reported 3 leadership change filings to the SEC under Item 5.02 of Form 8-K, from March 30, 2026 to October 26, 2026 (Form 8-K, October 26, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Neogen Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · In / out: Reported · Person: not named in the filing · 8-K/A, 2026-10-26
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-08-07
- · In / out: Reported · Person: not named in the filing · 8-K, 2026-03-30
Neogen Corp reported changes in 3 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-03-30 to 2026-10-26. Every row below is cited to the filing it comes from, and this page adds each new change as Neogen Corp files it.
Also on the record for Neogen Corp
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 7, 2026 | Stake report, Schedule 13G, by Neuberger Berman Group LLC | 7.6% of the class | 5%+ stakes | Source |
| May 14, 2026 | Stake report, Schedule 13G/A, by Clarkston Capital Partners, LLC | 1.01% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5.13% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 5.93% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Gates Capital Management, L.P. | 3.9% of the class | 5%+ stakes | Source |
| December 4, 2025 | Stake report, Schedule 13G/A, by ING GROEP NV | 3.99% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G/A, by Clarkston Capital Partners, LLC | 5.38% of the class | 5%+ stakes | Source |
| October 22, 2025 | Stake report, Schedule 13G, by ING GROEP NV | 6.47% of the class | 5%+ stakes | Source |
| August 14, 2025 | Stake report, Schedule 13G, by Gates Capital Management, L.P. | 5.9% of the class | 5%+ stakes | Source |
| August 13, 2025 | Stake report, Schedule 13G, by Clarkston Capital Partners, LLC | 6.44% of the class | 5%+ stakes | Source |
| July 30, 2025 | Stake report, Schedule 13G/A, by WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 4.3% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Neogen Corp now and the warning signs.
Free to see. No signup.
Keep reading
More on Neogen Corp and the records around it.
Neogen Corp elsewhere on the record
- 5%+ stake filings Jul 2026
- Who owns it
Companies that share a holder
- ING GROEP NV also filed stake reports on 1 other company: Tenax Therapeutics, Inc. (Sep 2026)
- Gates Capital Management, L.P. also filed stake reports on 6 other companies: Atkore Inc. (Aug 2026), MasterBrand, Inc. (Aug 2026), Acuren Corporation (Aug 2026)
- Clarkston Capital Partners, LLC also filed stake reports on 8 other companies: CLARIVATE PLC (May 2026), ENERGIZER HOLDINGS, INC. (May 2026), JOHN WILEY & SONS, INC. (May 2026)
Watch Neogen Corp
Get an email when Neogen Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Neogen Corp?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Neogen Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Neogen Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 13 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-26 | Reported | not named in the filing | 8-K/A, 2026-10-26 | ||
| 2026-08-07 | Reported | not named in the filing | 8-K, 2026-08-07 | ||
| 2026-03-30 | Reported | not named in the filing | 8-K, 2026-03-30 |
New leaders reset buying decisions — get the Full Report on Neogen Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Neogen Corp, with the record behind each one.
Find candidates like senior executive at Neogen CorpEvery change, in the filing's words
Reported
The Plan authorizes awards to non-employee directors and all employees of the Company or its subsidiaries, including named executive officers.
- disclosure regarding shareholder approval of the Neogen Corporation Amended and Restated Omnibus Incentive Plan.
- (e) Compensatory Arrangements of Certain Officers At the annual meeting of shareholders of Neogen Corporation (the "Company") held on October 1, 2026, the Company's shareholders approved the Neogen Corporation Amended and Restated Omnibus Incentive Plan (the "Plan").
- The Plan is an amendment and restatement of the Company's existing 2023 Omnibus Incentive Plan, previously approved by shareholders.
- The Plan provides for the grant of a variety of equity-based awards, such as stock options, stock appreciation rights, restricted stock and restricted stock units, performance stock units, and other stock-based awards.
- Subject to certain adjustments, the maximum number of shares that may be issued under the Plan is 31,350,000 shares.
- The Plan was described in more detail in, and a copy of the Plan was attached as Appendix A to, the Company's proxy statement filed with the SEC on August 21, 2026.
Reported
(b) On August 3, 2026, Mr. Thierry Bernard resigned from the Board of Directors of Neogen Corporation.
Reported
On March 30, 2026, Neogen Corporation (the "Company") announced that Amy Rocklin, the Company's Chief Legal and Administrative Officer, will leave the Company effective March 31, 2026.
Tools for this story
Each opens in a new tab, filled in for Neogen Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.